Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients.

Mordes DA, Prudencio M, Goodman LD, Klim JR, Moccia R, Limone F, Pietilainen O, Chowdhary K, Dickson DW, Rademakers R, Bonini NM, Petrucelli L, Eggan K.

Acta Neuropathol Commun. 2018 Jul 4;6(1):55. doi: 10.1186/s40478-018-0555-8.

2.

The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis.

Zhang Y, Burberry A, Wang JY, Sandoe J, Ghosh S, Udeshi ND, Svinkina T, Mordes DA, Mok J, Charlton M, Li QZ, Carr SA, Eggan K.

Genes Dev. 2018 Jul 1;32(13-14):929-943. doi: 10.1101/gad.313932.118. Epub 2018 Jun 27.

3.

Familial Parkinson's point mutation abolishes multiple system atrophy prion replication.

Woerman AL, Kazmi SA, Patel S, Aoyagi A, Oehler A, Widjaja K, Mordes DA, Olson SH, Prusiner SB.

Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):409-414. doi: 10.1073/pnas.1719369115. Epub 2017 Dec 26.

4.

MSA prions exhibit remarkable stability and resistance to inactivation.

Woerman AL, Kazmi SA, Patel S, Freyman Y, Oehler A, Aoyagi A, Mordes DA, Halliday GM, Middleton LT, Gentleman SM, Olson SH, Prusiner SB.

Acta Neuropathol. 2018 Jan;135(1):49-63. doi: 10.1007/s00401-017-1762-2. Epub 2017 Aug 28.

5.

Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage.

Hill SJ, Mordes DA, Cameron LA, Neuberg DS, Landini S, Eggan K, Livingston DM.

Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7701-E7709. Epub 2016 Nov 14.

6.

Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging.

Tian F, Yang W, Mordes DA, Wang JY, Salameh JS, Mok J, Chew J, Sharma A, Leno-Duran E, Suzuki-Uematsu S, Suzuki N, Han SS, Lu FK, Ji M, Zhang R, Liu Y, Strominger J, Shneider NA, Petrucelli L, Xie XS, Eggan K.

Nat Commun. 2016 Oct 31;7:13283. doi: 10.1038/ncomms13283.

7.

Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease.

Burberry A, Suzuki N, Wang JY, Moccia R, Mordes DA, Stewart MH, Suzuki-Uematsu S, Ghosh S, Singh A, Merkle FT, Koszka K, Li QZ, Zon L, Rossi DJ, Trowbridge JJ, Notarangelo LD, Eggan K.

Sci Transl Med. 2016 Jul 13;8(347):347ra93. doi: 10.1126/scitranslmed.aaf6038.

8.

Identification of neurotoxic cytokines by profiling Alzheimer's disease tissues and neuron culture viability screening.

Wood LB, Winslow AR, Proctor EA, McGuone D, Mordes DA, Frosch MP, Hyman BT, Lauffenburger DA, Haigis KM.

Sci Rep. 2015 Nov 13;5:16622. doi: 10.1038/srep16622.

9.

Case Records of the Massachusetts General Hospital. Case 30-2015: A 50-Year-Old Man with Cardiogenic Shock.

Wheeler TM, Baker JN, Chad DA, Zilinski JL, Verzosa S, Mordes DA.

N Engl J Med. 2015 Sep 24;373(13):1251-61. doi: 10.1056/NEJMcpc1415169.

PMID:
26398074
10.

Pigmented Lesions of the Nervous System and the Neural Crest: Lessons From Embryology.

Agarwalla PK, Koch MJ, Mordes DA, Codd PJ, Coumans JV.

Neurosurgery. 2016 Jan;78(1):142-55. doi: 10.1227/NEU.0000000000001010. Review.

PMID:
26355366
11.

Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.

Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, Patel S, Oehler A, Lowe JK, Kravitz SN, Geschwind DH, Glidden DV, Halliday GM, Middleton LT, Gentleman SM, Grinberg LT, Giles K.

Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5308-17. doi: 10.1073/pnas.1514475112. Epub 2015 Aug 31.

12.

Propagation of prions causing synucleinopathies in cultured cells.

Woerman AL, Stöhr J, Aoyagi A, Rampersaud R, Krejciova Z, Watts JC, Ohyama T, Patel S, Widjaja K, Oehler A, Sanders DW, Diamond MI, Seeley WW, Middleton LT, Gentleman SM, Mordes DA, Südhof TC, Giles K, Prusiner SB.

Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):E4949-58. doi: 10.1073/pnas.1513426112. Epub 2015 Aug 18.

13.

Case records of the Massachusetts General Hospital. Case 12-2015. A newborn boy with respiratory distress, lethargy, and hypernatremia.

Lin TY, Ebb DH, Boepple PA, Thiele EA, Rincon SP, Mordes DA.

N Engl J Med. 2015 Apr 16;372(16):1550-62. doi: 10.1056/NEJMcpc1400837. No abstract available.

PMID:
25875261
14.

VE1 antibody immunoreactivity in normal anterior pituitary and adrenal cortex without detectable BRAF V600E mutations.

Mordes DA, Lynch K, Campbell S, Dias-Santagata D, Nose V, Louis DN, Hoang MP.

Am J Clin Pathol. 2014 Jun;141(6):811-5. doi: 10.1309/AJCP37TLZLTUAOJL.

PMID:
24838325
15.

Glioblastoma mimicking an arteriovenous malformation.

Khanna A, Venteicher AS, Walcott BP, Kahle KT, Mordes DA, William CM, Ghogawala Z, Ogilvy CS.

Front Neurol. 2013 Sep 30;4:144. doi: 10.3389/fneur.2013.00144. eCollection 2013.

16.

Cytopathology of subacute thyroiditis.

Mordes DA, Brachtel EF.

Diagn Cytopathol. 2012 May;40(5):433-4. doi: 10.1002/dc.21847. Epub 2011 Nov 1. No abstract available.

PMID:
22045514
17.

A workshop on leadership for MD/PhD students.

Ciampa EJ, Hunt AA, Arneson KO, Mordes DA, Oldham WM, Vin Woo K, Owens DA, Cannon MD, Dermody TS.

Med Educ Online. 2011;16. doi: 10.3402/meo.v16i0.7075. Epub 2011 Aug 10.

18.

Dpb11 activates the Mec1-Ddc2 complex.

Mordes DA, Nam EA, Cortez D.

Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18730-4. doi: 10.1073/pnas.0806621105. Epub 2008 Nov 21.

19.

The basic cleft of RPA70N binds multiple checkpoint proteins, including RAD9, to regulate ATR signaling.

Xu X, Vaithiyalingam S, Glick GG, Mordes DA, Chazin WJ, Cortez D.

Mol Cell Biol. 2008 Dec;28(24):7345-53. doi: 10.1128/MCB.01079-08. Epub 2008 Oct 20.

20.

Activation of ATR and related PIKKs.

Mordes DA, Cortez D.

Cell Cycle. 2008 Sep 15;7(18):2809-12. Epub 2008 Sep 30.

21.

TopBP1 activates ATR through ATRIP and a PIKK regulatory domain.

Mordes DA, Glick GG, Zhao R, Cortez D.

Genes Dev. 2008 Jun 1;22(11):1478-89. doi: 10.1101/gad.1666208.

22.

Function of a conserved checkpoint recruitment domain in ATRIP proteins.

Ball HL, Ehrhardt MR, Mordes DA, Glick GG, Chazin WJ, Cortez D.

Mol Cell Biol. 2007 May;27(9):3367-77. Epub 2007 Mar 5.

Supplemental Content

Loading ...
Support Center